PPARG and familial dilated cardiomyopathy: After the administration of the test substances, PPAR-γ protein levels in the UCM, DCM-L, DCM-H, SCM, D, AS, and CC groups rebounded by 71% (p < 0.01), 116% (p < 0.001), 152% (p < 0.001), 84% (p < 0.01), 83% (p < 0.01), 63% (p < 0.05), and 84% (p < 0.01), respectively, compared with those in the TAA group.